Erivedge 150 mg

Erivedge 150 mg capsules are a prescription medication used to treat certain types of cancer. This oral capsule contains the active ingredient Vismodegib and is manufactured by Hoffmann-La Roche Limited in Canada.

Erivedge 150 mg capsules are primarily used in the treatment of basal cell carcinoma, a type of skin cancer. This medication works by targeting specific proteins involved in the growth and spread of cancer cells. Patients may wonder, 'What is Erivedge used for?' and the answer is that it is specifically indicated for advanced basal cell carcinoma that has spread or cannot be treated with surgery or radiation.

Common effects of Erivedge 150 mg capsules may include muscle spasms, hair loss, and changes in taste. Some users might experience fatigue or nausea. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Erivedge 150 mg capsules should be handled with care and stored as directed. It is important to follow the prescribing healthcare provider's instructions for use. Pregnant women should avoid handling this medication due to potential risks. Always consult a healthcare professional before starting any new medication.

Erivedge 150 mg capsules may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.